Senseonics, an American company from Maryland has got the green light from the competent authority (the FDA) for its Eversense, a device that monitors glucose in the body.
The system aims to completely replace the classic “finger prick” that diabetics do to assess their condition, reducing from a dozen or more of measurements at just 2 per day (to calibrate the machine): it is an important step forward, which with a small transmitting system allows you to have 90 days' worth of data at hand (on your mobile phone).
A little friend
Eversense is tiny, 1.8cm by 3.5mm, and it takes placed below skin in the position that once marked vaccinations, the top of the arm. The transmitter is then placed on this small base, who reads measurements and sends constant updates to your smartphone. If you take a shower you take it off, if not you want to bring it ditto with you, as the sensor continues to record and when you wear it new updates you.
Eversense is programmed to alert the wearer when sugar levels drop below the guard level: a providential vibration warns you that you have to run to shelter.
“This FDA approval will help diabetes patients greatly reduce their daily discomfort,” says Francine R. Kaufman, MD, Endocrinologist and head of the Senseonics medical division.
A great step forward towards total freedom, which one day not far away will allow diabetics to monitor glucose in real time with small implanted devices capable of reading body data by themselves.
Here is the device page: Eversense CGM
